Skip to main content
Clinical Trials/EUCTR2012-002692-34-AT
EUCTR2012-002692-34-ATActive, not recruitingNot Applicable

Clinical study for the assessment of safety and efficacy of Bezafibrate as a drug therapy for patients with mitochondrial myopathies - MitoFibrate CT1

niv.-Klinik für Kinder- und Jugendheilkunde0 sites16 target enrollmentStarted: February 26, 2013Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
16

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Ability to walk
  • Age: 2-50 years
  • confirmed Complex-I-defect or PDHc-defect
  • ability to cope with the requirements for study participation
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 8
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 8
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • previously known intolerance or other contra-indications for bezafibrat

Investigators

Sponsor
niv.-Klinik für Kinder- und Jugendheilkunde

Similar Trials